Application
A. Western blot analysis on MCF7 cell lysate using anti-phospho-p53 (pS392) RabMAb (Cat. #AJ1573g), 1:500 dilution. Cells were either (A) non treated or treated with Actinomycin D for (B) 3 hrs, (C) 6 hrs, and (D) 18hrs
Application
B. Immunohistochemical analysis of paraffin-embedded human prostate adenocarcinoma using anti-p53 (pS392) RabMAb (Cat. #AJ1573g)
Application
C. Immunofluorescent staining of A431 cells using anti-p53 (pS392) RabMAb (Cat. #AJ1573g)